Onconetix Conducts Exempt Equity Sales Under Regulation D
Company Announcements

Onconetix Conducts Exempt Equity Sales Under Regulation D

Onconetix (ONCO) has released an update to notify the public and investors about the unregistered sales of equity securities.

The Debenture issuance referenced in the Current Report on Form 8-K was conducted under an exemption from registration in compliance with Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Regulation D.

For further insights into ONCO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskOnconetix Announces Reverse Split to Meet Nasdaq Standards
TheFlyOnconetix announces 1-for-40 reverse stock split
GlobeNewswireOnconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App